Panacea Biotec - Quaterly Results

30 May 2024 Evaluate
The company witnessed a 7.13% growth in the revenue at Rs. 803.70 millions for the quarter ended March 2024 as compared to Rs. 750.20 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -13.70 millions as compared to Net Loss of Rs. -196.90 millions of corresponding quarter ended March 2023Operating Profit reported a sharp decline to 71.50 millions from 137.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 803.70 750.20 7.13 3596.00 2570.70 39.88 3596.00 2570.70 39.88
Other Income 163.90 102.70 59.59 249.10 344.30 -27.65 249.10 344.30 -27.65
PBIDT 71.50 137.00 -47.81 390.80 -281.90 -238.63 390.80 -281.90 -238.63
Interest 33.60 27.00 24.44 137.80 100.60 36.98 137.80 100.60 36.98
PBDT 37.90 110.00 -65.55 253.00 -382.50 -166.14 253.00 -382.50 -166.14
Depreciation 51.40 59.00 -12.88 210.90 245.00 -13.92 210.90 245.00 -13.92
PBT -13.50 51.00 -126.47 42.10 -627.50 -106.71 42.10 -627.50 -106.71
TAX 0.20 247.90 -99.92 6.60 247.90 -97.34 6.60 247.90 -97.34
Deferred Tax 0.20 247.90 -99.92 0.20 247.90 -99.92 0.20 247.90 -99.92
PAT -13.70 -196.90 -93.04 35.50 -875.40 -104.06 35.50 -875.40 -104.06
Equity 61.30 61.30 0.00 61.30 61.30 0.00 61.30 61.30 0.00
PBIDTM(%) 8.90 18.26 -51.28 10.87 -10.97 -199.10 10.87 -10.97 -199.10

Panacea Biotec Share Price

451.75 11.10 (2.52%)
01-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...